Vivera Pharmaceuticals, Inc.

Regulator action

United States. Named in 1 sanctions listing.

Screen this subject

Sanctions and listings1

Official designation
Securities and Exchange CommissionUS SEC Litigation ReleasesUnited StatesFiled
Reference 25538sec.gov sec.gov sec.gov

Supporting documents1

Vivera Pharmaceuticals, Inc., EFT Global Holdings, Inc. d/b/a Sentar Pharmaceuticals, and Paul P. Edalat
2022-09-30
https://www.sec.gov/enforcement-litigation/litigation-releases/lr-25538

Addresses1

Orange County, California

This page shows the public record as its publishers state it. A name here is not by itself a finding: whether a record refers to a particular person or company is what screening decides. Read the full notice.